San Diego, CA, United States of America

James Garrett Bonner

This inventor holds 1 USPTO granted patent. Top assignee: Basf Se Corporation. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Garrett Bonner: Innovator in Enzyme Technology

Introduction

James Garrett Bonner is a notable inventor based in San Diego, California. He has made significant contributions to the field of enzyme technology, particularly through his work on mannanase variants. With a focus on innovation, Bonner has secured a patent that showcases his expertise and dedication to advancing scientific knowledge.

Latest Patents

James Garrett Bonner holds a patent for "Mannanase Variants." This invention highlights his commitment to developing new solutions in enzyme applications. The patent reflects his innovative approach and understanding of biochemical processes.

Career Highlights

Bonner is currently employed at BASF SE Corporation, a leading global chemical company. His role at BASF allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects. His work is instrumental in enhancing the company's portfolio of enzyme technologies.

Collaborations

Throughout his career, Bonner has worked alongside talented colleagues, including Katie Kline and Amanda Rae Logue. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of innovative solutions.

Conclusion

James Garrett Bonner is a distinguished inventor whose work in enzyme technology has made a significant impact. His patent for mannanase variants exemplifies his innovative spirit and dedication to advancing the field. Through his role at BASF SE Corporation and collaborations with talented coworkers, Bonner continues to push the boundaries of scientific discovery.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…